The anti-inflammatory and antioxidant effects of GLP-1R agonist on kidney injury are well-known[11, 24, 25], but its direct effect on renal metabolism in obesity has rarely reported. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.